Belongs to

• Solid Tumor Oncology Division

Types of Work

["2020"]

[[["Journal Articles",318],["Meeting Abstracts",239],["Book Sections",19],["Editorials",3],["Reviews",3],["Books Whole",1],["Guidelines",1],["Miscellaneous",1]]]

[585]

Popular keywords

• adult
• aged
• article
• cisplatin
• female
• head and neck cancer
• human
• male
• middle aged
• priority journal

Recent Works

1. Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center

   Journal Article

   Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
   International Journal of Cancer (2021)

   Fulltext@MSK | Save
2. SWI/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies

   Journal Article

   Saqcena, M.; Leandro-Garcia, L. J.; Maag, J. L. V.; Tchekmedyian, V.; Krishnamoorthy, G. P.; Tamarapu, P. P.; Tiedje, V.; Reuter, V.; Knauf, J. A.; de Stanchina, E.; more...
   Cancer Discovery (2021)

   Fulltext@MSK | Save
3. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: A randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

   Journal Article

   Lee, N. Y.; Ferris, R. L.; Psyrri, A.; Haddad, R. I.; Tahara, M.; Bourhis, J.; Harrington, K.; Chang, P. M. H.; Lin, J. C.; Razaq, M. A.; more...
   Lancet Oncology (2021)

   Fulltext@MSK | Save